Any questions, comments, suggestions, etc. that you may forward or transmit via the website will - to the fullest extent permitted by applicable law - become and remain the property of Lundbeck and will be treated as non-confidential, non-proprietary information that Lundbeck may use at its own discretion.
If you suspect you have a health problem, we strongly recommend that you contact your physician.
The content of the website is subject to copyright protection and other intellectual property rights.
The company names, trade names, logos and all product names are trademarks owned by Lundbeck. Any misuse of these trademarks is expressly forbidden. The content of the website may not be copied other than for personal and non-commercial use, with all copyright or other proprietary notices retained. Except as expressly provided above, it is not permitted to copy, display, download, modify, reproduce or retransmit any information on this website without the express written consent of Lundbeck.
This website is not intended or designed to attract children under the age of 18 years. We do not knowingly collect personally identifiable data from any person we know to be under the age of 18 years.
Any changes to this document will be communicated promptly on this page. If you have any further questions regarding this document or the website in general, please do not hesitate to contact us.
Detailed information related to Lundbeck’s financial performance. Contact Palle Olesen, VP Investor Relations. + 45 3083 2426
A global pharmaceutical company specialized in brain diseases.
For general press enquiries, please call + 45 3643 4000